http://orcid.org/0000-0001-5125-2193
References
- Government of Canada. Bill C-30 an act to implement the comprehensive economic and trade agreement between Canada and the European Union and its member states and to provide for certain other measures. Ottawa, Canada: Parliament of Canada; 2017.
- International Comparative Legal Guides. International comparative legal guide to patents 2016 [Internet]. 2016. [cited 2017 Sep 8]. Available from: https://www.iclg.co.uk
- Department of Industry. Certificate of supplementary protection regulations regulatory impact analysis statement. Canada Gaz. 2017;151(28):1–7.
- Shajarizadeh A, Hollis A. Delays in the submission of new drugs in Canada. Can Med Assoc J. 2015;187(1):E47–E51.
- Department of Industry. Regulatory impact analysis statement, regulations amending the patented medicines (notice of compliance). Canada Gaz. 2017;151(28):1–20.
- Shajarizadeh A, Grootendorst P, Hollis A. Newton’s first law as applied to pharmacies: why entry order matters for generics. Int J Econ Bus. 2015;22(2):201-217.
- Hollis A. The importance of being first: evidence from Canadian generic pharmaceuticals. Health Econ. 2002;11(8):723-734.
- Hollis A. Sustainable financing of innovative therapies: a review of approaches. Pharmacoeconomics. 2016;34(10):971-980.